Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases

Journal of Immunology

Volumn 156, Issue 1, 1996, Pages 238-245

  Irvine, Kari R ^a   Rao, Jay B ^a,b   Rosenberg, Steven A ^a   Restifo, Nicholas P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CANCER VACCINE; CYTOKINE; DNA; IMMUNOLOGICAL ADJUVANT; N METHYL N NITROSOURETHAN; PLASMID DNA; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 7; RECOMBINANT VACCINE; TUMOR ANTIGEN; VIRUS VACCINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; COLON ADENOCARCINOMA; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; GENE TARGETING; INOCULATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; VIRUS RECOMBINANT;

AMINO ACID SEQUENCE; ANIMALS; CARCINOMA; COLONIC NEOPLASMS; CYTOKINES; DNA, NEOPLASM; GENE THERAPY; IMMUNOTHERAPY, ADOPTIVE; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED;

EID: 0030022796     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Greenberg, P. D., M. A. Cheever, and A. Fefer. 1981. H-2 restriction of adoptive immunotherapy of advanced tumors. J. Immunol. 126 2100.
2. Greenberg, P. D. 1991. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol. 49:281
3. Rosenberg, S. A., B. S. Packard, P. M. Aebersold, D. Solomon, S. L. Topalian, S. T. Toy, P. Simon, M. T. Lotze, J. C. Yang, C. A. Seipp, C. Simpson, C. Carter, S. Bock, D. Schwartzentruber, J. P. Wei, and D. E. White. 1988. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: preliminary report N. Engl J. Med. 319:1676.
4. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489.
5. Cox, A. L , J. Skipper, Y. Chen, R. A. Henderson, T. L. Darrow, I. Shabanowitz, V. H. Engelhard, D F. Hunt, and C L. Slingluff, Jr. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264:716.
6. Kawakami, Y., S. Eliyahu, C H Delgado, P. F Robbins, L. Rivoltini, S. L. Topalian, T. Miki, and S. A. Rosenberg. 1994 Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91:3515.
7. Kawakami, Y., S Eliyahu, C. H Delgado, P F. Robbins, K. Sakaguchi, E. Appella, J. R. Yannelli, G J. Adema, T. Miki, and S. A. Rosenberg 1994 Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 91:6458.
8. Robbins, P. F., M. El-Gamil, Y. F. Li, S. L. Topalian, L. Rivoltini, K. Sakaguchi, E. Appella, Y Kawakami, and S. A Rosenberg. 1995. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes J. Immunol. 154:5944
9. Pardoll, D. M. 1995. A new look for the 1990's. Science 369:357.
10. Estin, C. D , U. S. Stevenson, G. D. Plowman, S.-L. Hu, P. Sridham, I. Hellstrom, J P. Brown, and K. E. Hellstrom. 1988. Recombinant vaccinia virus against the human melanoma antigen p97 for use in immunotherapy. Proc. Natl. Acad. Sci. USA 85:1052.
11. Kantor, J., K Irvine, S. Abrams, H. Kaufman, J. DiPietro, and J. Schlom. 1992. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine J. Natl. Cancer Inst. 84:1084.
12. Wang, M , V. Bronte, P. W. Chen, L. Gritz, D. Panicali, S. A. Rosenberg, and N. P. Restifo. 1995. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. J. Immunol. 154:4685.
13. 12a Chen, P. W , M. Wang, V. Bronte, Y. Zhai, S. A Rosenberg, and N P. Restifo. 1996. Therapeutic anti-tumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen J Immunol In press.
14. McElrath, M. J., L. Corey, D Berger, M C. Hoffman, S Klucking, J. Dragavon, E. Peterson, and P. D. Greenberg. 1994. Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein, analysis of the durability of responses and effect of repeated boosting. J. Infect. Dis. 169:41.
15. Graham, B. S., T. J. Matthews, R. B. Belshe, M. L. Clements, R. Dolin, P. F. Wright, G J Gorse, D. H. Schwartz, M. C Reefer, and D. P. Bolognesi. 1993. Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults, the NIAID AIDS Vaccine Clinical Trials Network. J. Infect. Dis. 167 533.
16. Battegay, M , D. Moskophidis, H. Waldner, M A. Brundler, W. P. Fung-Leung, T W Mak, H. Hengartner, and R. M. Zinkernagel. 1993. Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. J. Immunol. 151:5408.
17. Cooney E L., A. C. Collier, P. D. Greenberg, R. W Coombs, J Zarling, D. E. Arditti, M. C. Hoffman, S. L. Hu, and L Corey 1991. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoproteins Lancet 337:567.
18. Wolff, J A , R W. Malone, P. Williams, W Chong, G. Acsadi, A. Jani, and P L. Felgner 1990 Direct transfer into mouse muscle in vivo. Science 247:1465
19. Davis, H L., R. G. Whalen, and B. A. Demeneix. 1993. Direct gene transfer into skeletal muscle in vivo, factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4:151.
20. Kozak, M. 1989. The scanning model for translation: an update. J. Cell Biol 108:229
21. Yang, N-S., J Burkholder, B. Roberts, B. Martinelli, and D. McCabe. 1990 In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl Acad. Sci. USA 87:9568.
22. Williams, R. S., S. A. Johnston, M. Riedy, M. J DeVit, S G. McElligott, and J C. Sanford. 1991. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc. Natl. Acad. Sci. USA 88:2726.
23. Fynan, E., R. G. Webster, D. H. Fuller, J R. Haynes, J. C. Santoro, and H L. Robinson. 1995. DNA vaccines: protective immunizations by parental, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90:11478.
24. Eisenbraun, M. D., D H. Fuller, and J R. Haynes 1993. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol. 12:791.
25. Fuller, D. H., and J. R. Haynes. 1994. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res. Hum. Retroviruses 10 1433
26. Pertmer, T. M., M. D Eisenbraun, D. McCabe, S. K. Prayaga, D. H. Fuller, and J. R. Haynes. 1995. Gene gun-based nucleic acid immunization, elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA Vaccine. In press
27. Acsadi, G., G. Dickson, D R. Love, A. Jani, F S. Walsh, A. Gurusinghe, J. A Wolff, and K. E. Davies. 1991. Human dystrophin expression in max mice after intramuscular injection of DNA constructs. Nature 352:815.
28. Vitadello, M , M. V. Schiaffino, A. Picard, M. Scarpa, and S. Schiaffino. 1994. Gene transfer in regenerating muscle. Hum. Gene Ther. 5 11.
29. Wolff, J. A., J. J. Ludtke, G. Acsadi, P. Williams, and A. Jam. 1992. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1:363
30. Tang, D., M. DeVit, and S. A. Johnston. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356:152
31. Ulmer, J. B., J. J. Donnelly, S E. Parker, G. H. Rhodes, P. L Felgner, V. J Dwarki, S. H. Gromkowsi, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C Perry, J. W Shiver, D. L. Montgomery, and M. A Lin 1993 Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745
32. Wang, B., E. U. Ugen, V. Srikantan, M. G. Agadjanyan, K. Dang, Y. Refaeh, A. Sato, J. Boyer, W. V. Williams, and D. B. Weiner. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:4156.
33. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1995. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein Proc. Natl. Acad. Sci USA 91:9866.
34. Pedroza Martins, L , L L. Lau, M S. Asano, and R. Ahmed 1995. DNA vaccination against persistent viral infection J. Virol. 69:2574.
35. Zarozinski, C. C., E. F Fynan, L. K. Selin, H. Robinson, and R. M. Welsh. 1995. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154:4010.
36. Conry, R. M., A. F. LoBuglio, J. Kantor, J. Schlom, F. Loechel, S. E. Moore, L A. Sumerel, D L Barlow, S. Abrams, and D. T Curiel. 1994. Immune response to a carcinoembryonic antigen polynucleotide vaccine Cancer Res. 54: 1164.
37. Conry, R M., A. F. LoBuglio, F. Loechel, S. E. Moore, L. A. Sumerel, D L Barlow, and D. T. Curiel. 1995. A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Ther. 2:59.
38. Wang, B., M. Merva, K. Dang, K Ugen, J. Boyer, W. V. Williams, and D B Weiner. 1994. DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen expressing cells. AIDS Res. Hum Retroviruses 10:21.
39. Brattain, M G , J. Strobel-Stevens, D. Fine, M. Webb, and A. M. Sarrif. 1980 Establishment of mouse colonic carcinoma cell lines with different metastatic properties. Cancer Res. 40:2142.
40. Sambrook, J , E. F. Fritsch, and T. Maniatis. 1989 Molecular Cloning, A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
41. Gavin, M. A., M. J. Gilbert, S. R Riddell, P. D Greenberg, and M. J. Bevan. 1993. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J Immunol. 151:3971.
42. Restifo, N P., F. Esquivel, Y. Kawakami, J. W. Yewdell, J. J Mulé, S A. Rosenberg, and J R. Bennink 1993. Identification of human cancers deficient in antigen processing J Exp. Med 177:265
43. Restifo, N. P., F. Esquivel, A. L. Asher, H. Stotter, R. J. Barth, J. R. Bennink, J. J. Mulé, J. W. Yewdell, and S. A. Rosenberg. 1991. Defective presentation of endogenous antigens by a murine sarcoma: implications for the failure of an anti-tumor immune response. J Immunol. 147:1453.
44. Mulé, J J , J. C. Yang, R. Lafrenière, S. Shu, and S. A. Rosenberg 1987 Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin-2. J. Immunol. 139:285.
45. Bronte, V., K. Tsung, J B. Rao, P. W. Chen, M. Wang, S. A. Rosenberg, and N. P. Restifo. 1995. IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases. J Immunol. 154: 5282.
46. Jicha, D. L., J. J. Mulé, and S A. Rosenberg 1991. Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy. J. Exp. Med. 174:1511.
47. Komschlies, K L., T A. Gregorio, M. E. Gruys, T. C. Back, C R. Falrynek, and R H. Wiltrout. 1994 Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases. J. Immunol. 153:5776.
48. Mulé, J. J., M D. Custer, W. D. Travis, and S. A. Rosenberg. 1992. Cellular mechanisms of the antitumor activity of recombinant IL-6 in mice J. Immunol. 148:2622.
49. Brunda, M. J., L. Luistro, R R. Warrier, R. B. Wright, B. R. Hubbard, M Murphy, S. F. Wolf, and M. K. Gately. 1993. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp. Med. 178:1223.
50. Hill, A. D., H P. Redmond, O. M. Austin, P A. Grace, and D. Bouchier-Hayes. 1993. Granulocyte-macrophage colony-stimulating factor inhibits tumour growth Br. J Surg. 80:1543
51. Topp, M. S., M. Koenigsmann, A. Mire-Sluis, D. Oberberg, F. Eitelbach, Z von Marschall, M Notter, B. Reufi, H. Stein, and E. Thiel. 1993. Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo. Blood 82:2837.
52. Tahara, H., and M. Lotze. 1995. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer. Gene Ther 2:96.
53. Takatsuki, F., A Okano, C. Suzuki, R. Chieda, Y. Takahara, T. Hirano, K. Tadamitsu, J. Hamuro, and Y. Akiyama 1988. Human IL-6/B cell stimulatory factor-2 augments murine antigen-specific antibody responses in vitro and in vivo. J. Immunol. 141:3072.
54. Afonso, L. C., T. M Scharton, L. Q Vieira, M. Wysocka, G. Trinchien, and P Scott. 1994 The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235.
55. Noguchi, Y , E. C. Richards, Y.-T. Chen, and L. J Old. 1995. Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proc. Natl Acad Sci. USA 92 2219.
56. Jicha, D. L., J. J. Mulé, and S A Rosenberg. 1991. Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy. J. Exp. Med 174:1511.
57. Inaba, K., M Inaba, N. Romani, H Aya, M. Deguchi, S Ikehara, S. Muramatsu, and R M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp. Med. 176:1693.
58. + T lymphocytes J Immunol. 151:2444.
59. + T cells through IL-12 produced Listeria-induced macrophages. Science 260:547.
60. Bertagnolli, M M., B.-Y. Lin, D. Young, and S H. Herrmann. 1992. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J. Immunol. 149:3778.
61. Sypek, J. P., C. L Chung, S. H Mayor, J M. Subramanyam, S. J Goldman, D. S Sieburth, S. F. Wolf, and R G. Schaub. 1993 Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp Med. 177:1797.
62. Chapman, B. S., R. M. Thayer, K. A. Vincent, and N. Haigwood. 1991. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res. 19:3979
63. Takai, Y., G G. Wong, S. C. Clark, S. J Burkoff, and S. H. Herrmann. 1988 B-cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes J. Immunol 140:508.
64. Rosenberg, S. A., J. J. Mulé, P J. Spiess, C. M. Reichert, and S. Schwarz. 1985. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high dose recombinant IL-2 J. Exp Med. 161:1169.
65. Radrizzani, M., P. Accornero, A. Amidei, A. Aeillo, D. Delia, R. Kurrle, and M. P. Colombo. 1995. IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 crosslinking and CD3/TCR activation or by IL-2 deprivation. Cell. Immunol 161:1421.
66. Mosmann, T. R 1991. Cytokine secretion patterns and cross-regulation of T cell subsets Immunol. Res. 10:183.
67. + T cells against the wild-type tumor: correlation with antigen presentation capability. J. Exp. Med. 175:1423.
68. Sun, W. H., J. K. Burkholder, J. Sun, J. Culp, J. Turner, X. G. Lu, T D. Pugh, W B. Ershler, and N.-S. Yang. 1995. In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc. Natl. Acad. Sci. USA 92:2889.
69. Mougneau, E , F. Altare, A E. Wakil, S. Zheng, T Coppola, Z -E. Wang, R. Waldmann, R. M. Locksley, and N. Glaichenhaus. 1995. Expression cloning of a protective Leishmania antigen. Science 268:563.
70. Xiang, Z., and H C. J. Ertl 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129.
71. Kundig, T M., M. F. Bachmann, L. Lefrancois, L. Puddington, H. Hengartner, and R M. Zinkernagel 1993. Nonimmunogenic tumor cells may efficiently restimulate tumor antigen-specific eytotoxic T cells. J. Immunol. 150:4450.
72. Hollstein, M., D. Sidransky, B. Vogelstein, and C. C Harris 1991. p53 mutations in human cancers. Science 253:49.
73. Gribben, J. G., L. Saporito, M Barber, K W. Blake, R. M Edwards, J D. Griffin, A S. Freedman, and L. M. Nadler. 1992. Bone marrows of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion Blood 80:1083.
74. Van den Eynde, B . B. Lethe, A. Van Pel, E. De Plaen, and T. Boon. 1991. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice J Exp. Med 173:1373.
75. Jiao, S. P., P. Williams, R. K. Berg, B. A. Hodgeman, L. Liu, G. Repetto, and J A. Wolff. 1992. Direct gene transfer into nonhuman primate myofibers in vivo. Hum. Gene Ther. 3 21
76. Johnson, R. P., S. A Hammond, A. Trocha, R F. Siliciano, and B. D. Walker 1994. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine J. Virol. 68:3145.